Agency is seeking comment from consumers on products.

The FDA is requesting that manufacturers of three GLP-1 receptor agonists remove information on risk for suicidal ideation ...

The request comes after a two-year review into reported links between GLP-1RAs and psychiatric adverse events.

Request based on a comprehensive review of data ...

Meanwhile, the FDA has asked manufacturers of flu vaccines to update their labels to include warnings about the risk of ...

WASHINGTON — The Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings ...

Industry expected to push back in favor of voluntary labeling A broad coalition of 28 leading consumer, public health, and nutrition organizations, alongside 12 academic researchers, has called on the ...

The FDA has told the makers of six flu vaccines that they need to add a notification to the label of their shots, warning of ...

The Food and Drug Administration is attempting to put a spotlight on the potential risks associated with prolonged use of opioid pain medications by mandating changes to the way those products are ...